Submitted:
26 February 2024
Posted:
27 February 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results
3.1. In Vitro Selection
- participant 3: there was a decrease in the number of metaphases in the 45,X lineage and a simultaneous increase in the number of metaphases of lineage 46,X+r(X ) over the period (p = 0.0274).
- participant 6: there was a decrease in the number of metaphases in the 45,X lineage and an increase in the number of metaphases in the 46,X+mar(X) lineage when comparing 48h and 72h incubation (p = 0.0234).
3.2. Proliferation Index (PI)
3.3. Sister Chromatid Exchange (SCE) Frequency
4. Discussion
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Radonova L, Svobodova T, Anger M. Regulation of the cell cycle in early mammalian embryos and its clinical implications. The International Journal of Developmental Biology. 2019 Feb 6;63(3-4–5):113–22. [CrossRef]
- Potapova TA, Zhu J, Li R. Aneuploidy and chromosomal instability: a vicious cycle driving cellular evolution and cancer genome chaos. Cancer Metastasis Rev. 2013 Dec;32(3–4):377–89. [CrossRef]
- Álvarez-Nava F, Soto‐Quintana M. The Hypothesis of the Prolonged Cell Cycle in Turner Syndrome. J Dev Biol. 2022 May 11;10(2):16. 11 May. [CrossRef]
- Oliveira RMR de, Verreschi IT do N, Lipay MVN, Eça LP, Guedes AD, Bianco B. Y chromosome in Turner syndrome: review of the literature. Sao Paulo Med J. 2009 Nov;127(6):373–8. [CrossRef]
- Gravholt CH, Viuff MH, Brun S, Stochholm K, Andersen NH. Turner syndrome: mechanisms and management. Nat Rev Endocrinol. 2019 Oct;15(10):601–14. [CrossRef]
- Marzuki NS, Anggaratri HW, Suciati LP, Ambarwati DD, Paramayuda C, Kartapradja H, et al. Diversity of sex chromosome abnormalities in a cohort of 95 Indonesian patients with monosomy X. Molecular Cytogenetics. 2011 Oct 12;4(1):23. [CrossRef]
- Simpson JL, Lebeau MM. Gonadal and statural determinants on the X chromosome and their relationship to in vitro studies showing prolonged cell cycles in 45,X; 46,X,del(X)(p11); 46,X,del(X)(q13); and 46,X,del(X)(q22) fibroblasts. Am J Obstet Gynecol. 1981 Dec 15;141(8):930-40. [CrossRef]
- Álvarez-Nava F, Lanes R. Epigenetics in Turner syndrome. Clin Epigenetics. 2018;10:45. [CrossRef]
- Trolle C, Nielsen MM, Skakkebæk A, Lamy P, Vang S, Hedegaard J, et al. Widespread DNA hypomethylation and differential gene expression in Turner syndrome. Sci Rep. 2016 Sep 30;6:34220. [CrossRef]
- Thompson SL, Bakhoum SF, Compton DA. Mechanisms of chromosomal instability. Curr Biol. 2010 Mar 23;20(6):R285-295. [CrossRef]
- Vanneste E, Voet T, Le Caignec C, Ampe M, Konings P, Melotte C, et al. Chromosome instability is common in human cleavage-stage embryos. Nat Med. 2009 May;15(5):577–83. [CrossRef]
- Salawu A, Wright K, Al-Kathiri A, Wyld L, Reed M, Sisley K. Sister Chromatid Exchange and Genomic Instability in Soft Tissue Sarcomas: Potential Implications for Response to DNA-Damaging Treatments. Sarcoma. 2018;2018:3082526. [CrossRef]
- Cobanoglu H, Cayir A. Assessment of the genotoxic potential of tetrachlorvinphos insecticide by cytokinesis-block micronucleus and sister chromatid exchange assays. Hum Exp Toxicol. 2021 Dec;40(12_suppl):S158–63. [CrossRef]
- Montenegro MM, Quaio CR, Palmeira P, Gasparini Y, Rangel-Santos A, Damasceno J, et al. Gene expression profile suggesting immunological dysregulation in two Brazilian Bloom’s syndrome cases. Mol Genet Genomic Med. 2020 Feb 19;8(4):e1133. [CrossRef]
- Bianco B, Nunes Lipay MV, Guedes AD, Verreschi ITN. Clinical implications of the detection of Y-chromosome mosaicism in Turner’s syndrome: report of 3 cases. Fertility and Sterility. 2008 Oct 1;90(4):1197.e17-1197.e20. [CrossRef]
- Bispo AVS, Burégio-Frota P, Oliveira dos Santos L, Leal GF, Duarte AR, Araújo J, et al. Y chromosome in Turner syndrome: detection of hidden mosaicism and the report of a rare X;Y translocation case. Reprod Fertil Dev. 2014 Oct;26(8):1176–82. [CrossRef]
- Barale R, Chelotti L, Davini T, Del Ry S, Andreassi MG, Ballardin M, et al. Sister chromatid exchange and micronucleus frequency in human lymphocytes of 1,650 subjects in an Italian population: II. Contribution of sex, age, and lifestyle. Environ Mol Mutagen. 1998;31(3):228–42. [CrossRef]
- Melaragno MI, Ribeiro MC, Smith M de A, Andrade JA, Erwenne CM. Sister chromatid exchange frequency in a retinoblastoma mosaic patient with del(13). Cancer Genet Cytogenet. 1988 Jun;32(2):177–81. [CrossRef]
- Oztas S, Gullulu G, Tatar A, Astam N, Akyol I, Karakuzu A, et al. Chromosome and sister chromatid exchange studies in Behcet’s patients. J Dermatol. 2006 Jun;33(6):406–10. [CrossRef]
- Xu J, Liu P, Meng X, Bai J, Fu S, Guan R, et al. Association between sister chromatid exchange and double minute chromosomes in human tumor cells. Molecular Cytogenetics. 2015 Nov 19;8(1):91. [CrossRef]
- Wilson DM, Thompson LH. Molecular mechanisms of sister-chromatid exchange. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2007 Mar 1;616(1):11–23. [CrossRef]
- Latt SA, Schreck RR. Sister chromatid exchange analysis. Am J Hum Genet. 1980 May;32(3):297–313.
- Bortolai A, Melaragno MI. Cell-cycle kinetics of cell lines from patients with chromosomal mosaicism. Ann Genet. 2001 Apr-Jun;44(2):93-7. [CrossRef]
- Rafferty K, Archer KJ, Turner K, Brown R, Jackson-Cook C. Trisomy 21-associated increases in chromosomal instability are unmasked by comparing isogenic trisomic/disomic leukocytes from people with mosaic Down syndrome. PLoS One. 2021;16(7):e0254806. [CrossRef]
- Moorhead PS, Nowell PC, Mellman WJ, Battips DM, Hungerford DA. Chromosome preparations of leukocytes cultured from human peripheral blood. Experimental Cell Research. 1960 Sep 1;20(3):613–6. [CrossRef]
- Perry P, Wolff S. New Giemsa method for the differential staining of sister chromatids. Nature. 1974 Sep;251(5471):156–8. [CrossRef]
- Korenberg JR, Freedlender EF. Giemsa technique for the detection of sister chromatid exchanges. Chromosoma. 1974;48(4):355–60. [CrossRef]
- Butler MG. Sister Chromatid Exchanges in A Male With A Y/Y Translocation. Trans Nebr Acad Sci Affil Soc. 1981;9:9–11.
- Heidemann A, Schmalenberger B, Zankl H. Sister chromatid exchange and lymphocyte proliferation in a Down syndrome mosaic. Clin Genet. 1983 Feb;23(2):139–42. [CrossRef]
- Santovito A, Gendusa C, Cervella P. Evaluation of baseline frequency of sister chromatid exchanges in an Italian population according to age, sex, smoking habits, and gene polymorphisms. Am J Hum Biol. 2017 Nov;29(6). [CrossRef]
- Landi S, Frenzilli G, Milillo PC, Cocchi L, Sbrana I, Scapoli C, et al. Spontaneous sister chromatid exchange and chromosome aberration frequency in humans: the familial effect. Mutat Res. 1999 Aug 18;444(2):337–45. [CrossRef]
- Laurie CC, Laurie CA, Rice K, Doheny KF, Zelnick LR, McHugh CP, et al. Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet. 2012 May 6;44(6):642–50. [CrossRef]
- Denes AM, Landin-Wilhelmsen K, Wettergren Y, Bryman I, Hanson C. The proportion of diploid 46,XX cells increases with time in women with Turner syndrome--a 10-year follow-up study. Genet Test Mol Biomarkers. 2015 Feb;19(2):82–7. [CrossRef]
- Machiela MJ, Zhou W, Karlins E, Sampson JN, Freedman ND, Yang Q, et al. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome. Nat Commun. 2016 Jun 13;7(1):11843. [CrossRef]
- Catalán J, Falck GCM, Norppa H. The X Chromosome Frequently Lags Behind in Female Lymphocyte Anaphase. Am J Hum Genet. 2000 Feb;66(2):687–91. [CrossRef]
- Payne M, Hickson ID. Genomic instability and cancer: lessons from analysis of Bloom’s syndrome. Biochem Soc Trans. 2009 Jun;37(Pt 3):553–9. [CrossRef]
- Iqbal MA, Martin AO, Simpson JL. Increased sister chromatid exchanges in human cell lines characterized by monosomy X or structural abnormalities of the X chromosome. Hum Genet. 1984;68(3):205–8. [CrossRef]
- Gravholt CH, Viuff M, Just J, Sandahl K, Brun S, van der Velden J, et al. The Changing Face of Turner Syndrome. Endocr Rev. 2023 Jan 12;44(1):33–69. [CrossRef]
- Thunström S, Landin-Wilhelmsen K, Bryman I, Hanson C. Side differences in the degree of mosaicism of the buccal mucosa in Turner syndrome. Mol Genet Genomic Med. 2019 Aug 29;7(10):e00938. [CrossRef]
- Liehr T, Mrasek K, Hinreiner S, Reich D, Ewers E, Bartels I, et al. Small Supernumerary Marker Chromosomes (sSMC) in Patients with a 45,X/46,X,+mar Karyotype – 17 New Cases and a Review of the Literature. Sexual Development. 2008 Jan 18;1(6):353–62. [CrossRef]
- Wang H, Wang T, Yang N, He Y, Chen L, Hong L, et al. The clinical analysis of small supernumerary marker chromosomes in 17 children with mos 45,X/46,X,+mar karyotype. Oncol Lett. 2017 Jun;13(6):4385–9. [CrossRef]








| Participant | Karyotype by conventional cytogenetics and FISH | Age (yr.) |
|---|---|---|
| 1 | mos45,X/46,XX | 27 |
| 2 | mos45,X/46,XX | 30 |
| 3 | mos45,X/46,X,ish.r(X)(DXZ1+,XIST++) | 16 |
| 4 | mos45,X/46,X,+mar.ish.der(Y)(SHOX++,SRY ++,wcpY+) | 11 |
| 5 | mos45,X/46,X,+mar.ish.der(X)(DXZ1+,XIST+) | 19 |
| 6 | mos45,X/46,X,+mar.ish.der(X)(DXZ1+,XIST+) | 11 |
| 7 | mos45,X/46,X,+mar.ish. der(X)(DXZ1+,XIST-) | 1.7 |
| 8 | mos45,X/46,X,+mar.ish.der(X)(DXZ1+,XIST++) | 12 |
| 9 | mos45,X/46,XY | 31 |
| 10 | mos45,X/46,X,+mar.ish.der(X)(DXZ1+,XIST+) | 15 |
| 11 | mos45,X/46,X,+mar.ish.der(X)(DXZ1+,XIST+) | 5 |
| 12 | mos45,X/46,X,+mar.ish.der(X)(DXZ1+,XIST++) | 17 |
| 13 | mos45,X/46,X,+mar.ish.der(X)(DXZ1+,XIST+) | 22 |
| 14 | mos45,X/46,X+mar.ish.der(Y)(ENY++) | 23 |
| 15 | mos45,X/46,XX | 42 |
| 16 | mos45,X/46,X,+mar.ish.der(X)(DXZ1+,XIST+) | 19 |
| 17 | mos45,X/46,X,i(Y)(pter->p10->pter).ish (ENY++,SRY++,SHOX++,DYZ3++) | 14 |
| PI | N | Mean | Std. Err. | Std. Dev.(±) | 95% Conf. Interval | |
|---|---|---|---|---|---|---|
| 45,X lineage | 17 | 2.005 | 0.026 | 0.106 | 1.951 | 2.060 |
| 46,XN lineage | 17 | 2.078 | 0.038 | 0.155 | 1.998 | 2.157 |
| t =-2.3211 | p = 0.0338 | |||||
| PI | Mean | Std. Dev.(±) | Min | Max | 45,X PI | 46,XN PI |
|---|---|---|---|---|---|---|
| 45,X lineage | 2.005 | 0.106 | 1.80 | 2.18 | 1.000 | |
| 46,XN lineage | 2.078 | 0.155 | 1.84 | 2.48 | 0.5716 | 1.000 |
| Participants | Lineages | SCE mean | p value | PI | χ2 | p value |
|---|---|---|---|---|---|---|
| 1 | 45,X 46,XX |
3.15 2.6 |
0.0551 | 2.05 2.15 |
0.9387 | 0.6254 |
| 2 | 45,X 46,XX |
3.65 2.95 |
0.0454* | 2.18 2.27 |
0.9859 | 0.6108 |
| 3 | 45,X 46,X,+r(X) |
3.95 5.25 |
0.0046** | 2.06 2.16 |
1.016 | 0.6017 |
| 4 | 45,X 46,X,+mar(Y) |
4.45 3.55 |
0.0046** | 2.10 2.10 |
0.1640 | 0.9213 |
| 5 | 45,X 46,X,+mar(X) |
4.15 3.75 |
0.3583 | 2.02 1.98 |
0.7311 | 0.6938 |
| 6 | 45,X 46,X,+mar(X) |
3.55 4.25 |
0.0779 | 2.04 2.12 |
0.4380 | 0.8033 |
| 7 | 45,X 46,X,+mar(X) |
4.2 5.55 |
0.0100** | 2.10 2.10 |
0,1829 | 0.9126 |
| 8 | 45,X 46,X,+mar(X) |
3.45 4.2 |
0.0714 | 1.88 1.88 |
0.1814 | 0.9133 |
| 9 | 45,X 46,XY |
3.6 3.75 |
0.7805 | 2.06 1.92 |
2,123 | 0.3460 |
| 10 | 45,X 46,X,+mar(X) |
3.7 4.5 |
0.1183 | 1.98 2.16 |
3,187 | 0.2032 |
| 11 | 45,X 46,X,+mar(X) |
3.5 4.1 |
0.1544 | 2.04 2.12 |
0.4600 | 0.7945 |
| 12 | 45,X 46,X,+mar(X) |
3.8 4.85 |
0.0105* | 1.94 2.08 |
1.432 | 0.4886 |
| 13 | 45,X 46,X+mar(X) |
4.3 5.25 |
0.0745 | 1.84 1.90 |
0.2741 | 0.8719 |
| 14 | 45,X 46,X+mar(Y) |
4.4 4.7 |
0.5248 | 2.14 2.04 |
0.7435 | 0.6895 |
| 15 | 45,X 46,XX |
3.75 4.05 |
0.4647 | 1.80 2.06 |
4.399 | 0.1108 |
| 16 | 45,X 46,X,+mar(X) |
4 4.3 |
0.5228 | 1.90 1.90 |
0.1673 | 0.9198 |
| 17 | 45,X 46,X,i(Yp) |
4.35 3.3 |
0.0703 | 1.96 2.06 |
1.000 | 0.6065 |
| SCE | N | Mean | Std. Err. | Std. Dev. (±) | 95% Conf. Interval | |
|---|---|---|---|---|---|---|
| 45,X | 17 | 3.879 | 0.093 | 0.383 | 3.682 | 4.076 |
| 46,XN | 17 | 4.112 | 0.227 | 0.934 | 3.631 | 4.592 |
| t = -1.1012 | p=0.2871 | |||||
| SCE | Mean | Std. Dev (±) | Min | Max | SCE 45,X | SCE 46,XN |
|---|---|---|---|---|---|---|
| 45,X | 3.879 | 0.383 | 3.15 | 4.45 | 1.000 | |
| 46,XN | 4.112 | 0.934 | 1.95 | 5.55 | 0.3615 | 1.000 |
| Karyotype | 46,XX | 46,Xr(X) | 46,X+mar(Y) | 46,X+mar(X) | 46,XY | 46,X+i(Yp) |
|---|---|---|---|---|---|---|
| 45,X | 0.0151* | 0.0007* | 0.9995 | <0.0001* | >0.9999 | 0.8204 |
| 46,XX | <0.0001* | 0.0328* | <0.0001* | 0.9542 | >0.9999 | |
| 46,Xr(X) | 0.0841 | 0.4991 | <0.0198* | 0.0004* | ||
| 46,X+mar(Y) | 0.9079 | 0.9998 | 0,5310 | |||
| 46,X+mar(X) | 0.3630 | 0.0060* | ||||
| 46,XY | 0.9997 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).